A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase
Top Cited Papers
- 22 June 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 535 (7611), 252-257
- https://doi.org/10.1038/nature18611
Abstract
Immunomodulatory drugs bind to cereblon (CRBN) to confer differentiated substrate specificity on the CRL4CRBN E3 ubiquitin ligase. Here we report the identification of a new cereblon modulator, CC-885, with potent anti-tumour activity. The anti-tumour activity of CC-885 is mediated through the cereblon-dependent ubiquitination and degradation of the translation termination factor GSPT1. Patient-derived acute myeloid leukaemia tumour cells exhibit high sensitivity to CC-885, indicating the clinical potential of this mechanism. Crystallographic studies of the CRBN–DDB1–CC-885–GSPT1 complex reveal that GSPT1 binds to cereblon through a surface turn containing a glycine residue at a key position, interacting with both CC-885 and a ‘hotspot’ on the cereblon surface. Although GSPT1 possesses no obvious structural, sequence or functional homology to previously known cereblon substrates, mutational analysis and modelling indicate that the cereblon substrate Ikaros uses a similar structural feature to bind cereblon, suggesting a common motif for substrate recruitment. These findings define a structural degron underlying cereblon ‘neosubstrate’ selectivity, and identify an anti-tumour target rendered druggable by cereblon modulation.Keywords
This publication has 32 references indexed in Scilit:
- Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDSNature, 2015
- Current treatment landscape for relapsed and/or refractory multiple myelomaNature Reviews Clinical Oncology, 2014
- Structure of the human Cereblon–DDB1–lenalidomide complex reveals basis for responsiveness to thalidomide analogsNature Structural & Molecular Biology, 2014
- Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomideLeukemia, 2012
- Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomideBlood, 2011
- The Ikaros gene family: Transcriptional regulators of hematopoiesis and immunityMolecular Immunology, 2011
- Identification of a Primary Target of Thalidomide TeratogenicityScience, 2010
- DDB1 functions as a linker to recruit receptor WD40 proteins to CUL4–ROC1 ubiquitin ligasesGenes & Development, 2006
- CUL4–DDB1 ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates histone methylationNature, 2006
- A Family of Diverse Cul4-Ddb1-Interacting Proteins Includes Cdt2, which Is Required for S Phase Destruction of the Replication Factor Cdt1Molecular Cell, 2006